BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 9212017)

  • 1. Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation Therapy Oncology Group (RTOG) 92-04.
    Komaki R; Scott C; Ettinger D; Lee JS; Fossella FV; Curran W; Evans RF; Rubin P; Byhardt RW
    Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):149-55. PubMed ID: 9212017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated high-dose radiotherapy alone or combined with either concomitant or sequential chemotherapy; treatments of choice in patients with Non-Small Cell Lung Cancer.
    Uitterhoeve AL; Koolen MG; van Os RM; Koedooder K; van de Kar M; Pieters BR; Koning CC
    Radiat Oncol; 2007 Jul; 2():27. PubMed ID: 17659094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction gemcitabine in standard dose or prolonged low-dose with cisplatin followed by concurrent radiochemotherapy in locally advanced non-small cell lung cancer: a randomized phase II clinical trial.
    Vrankar M; Zwitter M; Bavcar T; Milic A; Kovac V
    Radiol Oncol; 2014 Dec; 48(4):369-80. PubMed ID: 25435850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose and Fractionation in Radiation Therapy of Curative Intent for Non-Small Cell Lung Cancer: Meta-Analysis of Randomized Trials.
    Ramroth J; Cutter DJ; Darby SC; Higgins GS; McGale P; Partridge M; Taylor CW
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):736-747. PubMed ID: 27639294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538.
    Bogart J; Wang X; Masters G; Gao J; Komaki R; Gaspar LE; Heymach J; Bonner J; Kuzma C; Waqar S; Petty W; Stinchcombe TE; Bradley JD; Vokes E
    J Clin Oncol; 2023 May; 41(13):2394-2402. PubMed ID: 36623230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer.
    Wang BY; Zhang J; Wang JL; Sun S; Wang ZH; Wang LP; Zhang QL; Lv FF; Cao EY; Shao ZM; Fais S; Hu XC
    J Exp Clin Cancer Res; 2015 Aug; 34(1):85. PubMed ID: 26297142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Explainable Artificial Intelligence to Identify Dosimetric Predictors of Toxicity in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Secondary Analysis of RTOG 0617.
    Ladbury C; Li R; Danesharasteh A; Ertem Z; Tam A; Liu J; Hao C; Li R; McGee H; Sampath S; Williams T; Glaser S; Khasawneh M; Liao Z; Lee P; Ryckman J; Shaikh P; Amini A
    Int J Radiat Oncol Biol Phys; 2023 Dec; 117(5):1287-1296. PubMed ID: 37406826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weekly paclitaxel, gemcitabine, and external irradiation followed by randomized farnesyl transferase inhibitor R115777 for locally advanced pancreatic cancer.
    Rich TA; Winter K; Safran H; Hoffman JP; Erickson B; Anne PR; Myerson RJ; Cline-Burkhardt VJ; Perez K; Willett C
    Onco Targets Ther; 2012; 5():161-70. PubMed ID: 22977306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoradiotherapy for advanced head and neck cancer - Analysis of a prospective, randomized trial.
    Mitra D; Basu S; Deb AR; Rashid MA; Sur PK
    Indian J Otolaryngol Head Neck Surg; 2006 Oct; 58(4):360-3. PubMed ID: 23120348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix.
    Peters WA; Liu PY; Barrett RJ; Stock RJ; Monk BJ; Berek JS; Souhami L; Grigsby P; Gordon W; Alberts DS
    J Clin Oncol; 2023 Oct; 41(29):4605-4612. PubMed ID: 37797409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Outcomes After Concurrent Once- or Twice-Daily Chemoradiation in Limited-Stage Small Cell Lung Cancer: A Brief Report From the CONVERT Trial.
    Walls GM; Mistry H; Barlesi F; Bezjak A; Pechoux CL; O'Brien M; Van Meerbeeck JP; Blackhall F; Faivre-Finn C
    Int J Radiat Oncol Biol Phys; 2024 Mar; ():. PubMed ID: 38521132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of whole brain radiotherapy with concomitant thalidomide versus whole brain radiotherapy alone in brain metastases.
    Chyrmang D; Devi YS; Baidya K; Singh LJ; Nongrum DL; Devi ND
    J Cancer Res Ther; 2024 Jan; 20(1):255-260. PubMed ID: 38554330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of the Time-to-Event Continuous Reassessment Method Design in a Phase I Platform Trial Testing Novel Radiotherapy-Drug Combinations-CONCORDE.
    Walker K; Hinsley S; Phillip R; Oughton JB; Murden G; Chalmers AJ; Faivre-Finn C; Greystoke A; Brown SR;
    JCO Precis Oncol; 2022 Nov; 6():e2200133. PubMed ID: 36446040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a Propolis-Based Syrup (FARINGEL) in Preventing Radiation-Induced Esophagitis in Locally Advanced Lung Cancer.
    Ippolito E; Floreno B; Rinaldi CG; Trodella L; Meroni FL; Iurato A; D'Angelillo RM; Ramella S; Fiore M
    Chemotherapy; 2018 Mar; 63(2):76-82. PubMed ID: 29554652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of Cardiotoxicity Endpoints in Prospective Trials Involving Chest Radiation Therapy: A Review of Registered, Latter-Phase Studies.
    Prasad RN; Miller ED; Addison D; Bazan JG
    Front Oncol; 2022; 12():808531. PubMed ID: 35223489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung Organotypic Slices Enable Rapid Quantification of Acute Radiotherapy Induced Toxicity.
    Dubail M; Heinrich S; Portier L; Bastian J; Giuliano L; Aggar L; Berthault N; LondoƱo-Vallejo JA; Vilalta M; Boivin G; Sharma RA; Dutreix M; Fouillade C
    Cells; 2023 Oct; 12(20):. PubMed ID: 37887279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combinatorial Approaches for Chemotherapies and Targeted Therapies With Radiation: United Efforts to Innovate in Patient Care.
    Jabbour SK; Kumar R; Anderson B; Chino JP; Jethwa KR; McDowell L; Lo AC; Owen D; Pollom EL; Tree AC; Tsang DS; Yom SS
    Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1240-1261. PubMed ID: 38216094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 91-06.
    Komaki R; Scott C; Lee JS; Urtasun RC; Byhardt RW; Emami B; Andras EJ; Asbell SO; Rotman M; Cox JD
    Am J Clin Oncol; 1997 Oct; 20(5):435-40. PubMed ID: 9345325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With Stage II/III Non-Small Cell Lung Cancer and Poor Performance Status: A Randomized Clinical Trial.
    Iyengar P; Zhang-Velten E; Court L; Westover K; Yan Y; Lin MH; Xiong Z; Patel M; Rivera D; Chang J; Saunders M; Shivnani A; Lee A; Hughes R; Gerber D; Dowell J; Gao A; Heinzerling J; Li Y; Ahn C; Choy H; Timmerman R
    JAMA Oncol; 2021 Oct; 7(10):1497-1505. PubMed ID: 34383006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CIAPIN1 Targeted NHE1 and ERK1/2 to Suppress NSCLC Cells' Metastasis and Predicted Good Prognosis in NSCLC Patients Receiving Pulmonectomy.
    Wang J; Zhou Y; Ma L; Cao S; Gao W; Xiong Q; Wang K; Yang L
    Oxid Med Cell Longev; 2019; 2019():1970818. PubMed ID: 31093311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.